Cleared Traditional

K191394 - ILLUMISITE Platform

K191394 is the FDA 510(k) clearance for ILLUMISITE Platform by Covidien, LLC. It is a Class 2 Radiology device (product code JAK) cleared through the Traditional 510(k) pathway after a 75-day FDA review.

K191394 · Covidien, LLC · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2019
Decision
75d
Days
Class 2
Risk

K191394 is an FDA 510(k) clearance for the ILLUMISITE Platform. Classified as System, X-ray, Tomography, Computed (product code JAK), Class II - Special Controls.

Submitted by Covidien, LLC (Plymouth, US). The FDA issued a Cleared decision on August 7, 2019 after a review of 75 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Covidien, LLC devices

Submission Details

510(k) Number K191394 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 24, 2019
Decision Date August 07, 2019
Days to Decision 75 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d faster than avg
Panel avg: 107d · This submission: 75d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JAK System, X-ray, Tomography, Computed
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAK System, X-ray, Tomography, Computed

All 586
Devices cleared under the same product code (JAK) and FDA review panel - the closest regulatory comparables to K191394.
SCENARIA View
K190841 · Hitachi Healthcare Americas · Sep 2019
AI-Rad Companion (Cardiovascular)
K183268 · Siemens Medical Solutions USA, Inc. · Sep 2019
Aquilion ONE (TSX-306A/3) V10.0
K192188 · Canon Medical Systems Corporation · Sep 2019
Access CT
K191136 · Philips Healthcare (Suzhou) Co., Ltd. · Jul 2019
AI-Rad Companion (Pulmonary)
K183271 · Siemens Medical Solutions USA, Inc. · Jul 2019
Revolution CT, Revolution CT ES, Revolution Apex, Revolution CT with Apex edition
K191777 · Ge Medical Systems, LLC · Jul 2019